Characterization and Molecular Docking Analysis for the Supramolecular Interaction of Lidocaine with β-Cyclodextrin

References

• A. Villiers, “Sur la Fermentation de la Fécule Par l’action du Ferment Butyrique Comptes Rendus de l,” Académie des Sciences, no. 112 (1891): 536–8.
   Google Scholar
• R. Villalonga, R. Cao, and A. Fragoso, “Supramolecular Chemistry of Cyclodextrins in Enzyme Technology,” Chemical Reviews 107, no. 7 (2007): 3088–16.
   PubMed Web of Science ®Google Scholar
• R. Breslo, and S. D. Dong, “Biomimetic Reactions Catalyzed by Cyclodextrins and Their Derivatives,” Chemical Reviews 98, no. 5 (1998): 1997–11.
   PubMed Web of Science ®Google Scholar
• M. E. Davis, and M. E. Brewster, “Cyclodextrin-Based Pharmaceutics: Past, Present and Future,” Nature Reviews. Drug Discovery 3, no. 12 (2004): 1023–35.
   PubMed Web of Science ®Google Scholar
• M. V. Rekharsky, and Y. Inoue, “Complexation Thermodynamics of Cyclodextrins,” Chemical Reviews 98, no. 5 (1998): 1875–18.
   PubMed Web of Science ®Google Scholar
• T. Irie, and K. Uekama, “Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation,” Journal of Pharmaceutical Sciences 86, no. 2 (1997): 147–62.
   PubMed Web of Science ®Google Scholar
• E. Marttin, J. C. Verhoef, and F. W. Merkus, “Efficacy, Safety and Mechanism of Cyclodextrins as Absorption Enhancers in Nasal Delivery of Peptide and Protein Drugs,” Journal of Drug Targeting 6, no. 1 (1998): 17–36.
   PubMed Web of Science ®Google Scholar
• C. B. Berde, and G. R. Strichartz, “Local Anesthetics,” Miller's Anesthesia 7, no. 7 (2010): 913–39.
   Google Scholar
• O. Galbes, A. Bourret, K. Nouette-Gaulain, F. Pillard, S. Matecki, G. Py, J. Mercier, X. Capdevila, and A. Philips, “N-Acetylcysteine Protects against Bupivacaine-Induced Myotoxicity Caused by Oxidative and Sarcoplasmic Reticulum Stress in Human Skeletal Myotubes,” Anesthesiology 113, no. 3 (2010): 560–9.
   PubMed Web of Science ®Google Scholar
• S. L. Piper, and H. T. Kim, “Comparison of Ropivacaine and Bupivacaine Toxicity in Human Articular Chondrocytes,” The Journal of Bone and Joint Surgery 5, no. 90 (2008): 986–91.
   Google Scholar
• C. James, “Long-Term Consequences of Anesthetic Management,” Anesthesiology 1, no. 111 (2009): 1–4.
   Google Scholar
• H. Wada, S. Seki, T. Takahashi, N. Kawarabayashi, H. Higuchi, Y. Habu, S. Sugahara, and T. Kazama, “Combined Spinal and General Anesthesia Attenuates Liver Metastasis by Preserving TH1/TH2 Cytokine Balance,” Anesthesiology 106, no. 3 (2007): 499–06.
   PubMed Web of Science ®Google Scholar
• K. Ogawa, M. Hirai, T. Katsube, M. Murayama, K. Hamaguchi, T. Shimakawa, Y. Naritake, T. Hosokawa, and T. Kajiwara, “Suppression of Cellular Immunity by Surgical Stress,” Surgery 127, no. 3 (2000): 329–36.
   PubMed Web of Science ®Google Scholar
• H. Nagasaka, S. Ohno, K. Kobayashi, and H. Sakagami, “Effect of Anesthetics on Malignant Tumor Cells (a Review) 10,” Masui 10, no. 58 (2009): 1216–25.
   Google Scholar
• B. K. Ross, B. Coda, and C. H. Heath, “Local Anesthetic Distribution in a Spinal Model: A Possible Mechanism of Neurologic Injury after Continuous Spinal Anesthesia,” Regional Anaesthesia 2, no. 17 (1992): 69–77.
   Google Scholar
• T. Kishimoto, A. W. Bollen, and K. Drasner, “Comparative Spinal Neurotoxicity of Prilocaine and Lidocaine,” Anesthesiology 97, no. 5 (2002): 1250–3.
   PubMed Web of Science ®Google Scholar
• T. Jonnesco, “ Remarks on General Spinal Analgesia,” British Medical Journal 2, no. 2550 (1909): 1396–401.
   PubMedGoogle Scholar
• A. W. Parr, D. E. Zoutman, and J. S. Davidson, “Antimicrobial Activity of Lidocaine against Bacteria Associated with Nosocomial Wound Infection,” Annals of Plastic Surgery 3, no. 43 (1999): 239–45.
   Google Scholar
• R. M. Schmidt, and H. S. Rosenkranz, “Antimicrobial Activity of Local Anaesthetics: Lidocaine and Procaine,” Journal of Infectious Diseases 121, no. 6 (1970): 597–12.
   PubMed Web of Science ®Google Scholar
• W. Xing, D.-T. Chen, J.-H. Pan, Y.-H. Chen, Y. Yan, Q. Li, R.-F. Xue, Y.-F. Yuan, and W.-A. Zeng, “Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells in Vitro and in a Xenograft Model in Vivo,” Anesthesiology 126, no. 5 (2017): 868–81.
   PubMed Web of Science ®Google Scholar
• M. Sakaguchi, Y. Kuroda, and M. Hirose, “The Antiproliferative Effect of Lidocaine on Human Tongue Cancer Cells with Inhibition of the Activity of Epidermal Growth Factor Receptor,” Anesthesia and Analgesia 102, no. 4 (2006): 1103–7.
   PubMed Web of Science ®Google Scholar
• Y. Nishimura, Y. Miura, M. Maeda, H. Hayashi, M. Dong, H. Katsuyama, M. Tomita, F. Hyodoh, M. Kusaka, A. Uesaka, et.al, “Expression of the T Cell Receptor Vbeta repertoire in a human T cell resistant to asbestos-induced apoptosis and peripheral blood T cells from patients with silica and asbestos-related diseases ,” International Journal of Immunopathology and Pharmacology 19, no. 4 (2006): 795–05.
   PubMed Web of Science ®Google Scholar
• S. Soni, and A. Pal, “Spectroscopic Studies on Host–Guest Interactions of α- and β-Cyclodextrin with Lidocaine Hydrochloride and Procaine Hydrochloride,” Journal of Solution Chemistry 45, no. 5 (2016): 665–74.
   Web of Science ®Google Scholar
• V. R. Shaikh, S. S. Terdale, D. G. Hundiwale, and K. J. Patil, “Thermodynamic Studies of Drug–α-Cyclodextrin Interactions in Water at 298.15 K: Procaine Hydrochloride/Lidocaine Hydrochloride/Tetracaine Hydrochloride/Ranitidine Hydrochloride + α-Cyclodextrin + H2O Systems,” The Journal of Chemical Thermodynamics 68, no. 68 (2014): 161–8.
   Google Scholar
• A. Abou-Okeil, M. Rehan, S. M. El-Sawy, M. K. El-Bisi, O. A. Ahmed-Farid, and F. A. Abdel-Mohdy, “Lidocaine/β-Cyclodextrin Inclusion Complex as Drug Delivery System,” European Polymer Journal 108, no. 108 (2018): 304–10.
   Google Scholar
• L. Francisco, J. S. da Silva, F. A. do Carmo, V. R. de Almeida Borges, L. M. Monteiro, C. R. Rodrigues, L. M. Cabral, and V. P. de Sousa, “Preparation and Evaluation of Lidocaine Hydrochloride in Cyclodextrin Inclusion Complexes for Development of Stable Gel in Association with Chlorhexidine Gluconate for Urogenital Use,” International Journal of Nanomedicine 6, no. 6 (2011): 1143–54.
   PubMedGoogle Scholar
• R. Rajamohan, S. Kothai Nayaki, and M. Swaminathan, “Investigation on Association Behavior between 1-Aminoisoquinoline and β-Cyclodextrin in Solution and Solid State,” Journal of Molecular Liquids 220, no. 220 (2016): 918–25.
   Google Scholar